High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor

Hepatitis C virus (HCV) infections pose a major public health burden due to high chronicity rates and associated morbidity and mortality. A vaccine protecting against chronic infection is not available but would be important for global control of HCV infections. In this study, cell culture-based HCV...

Descripción completa

Detalles Bibliográficos
Autores principales: Offersgaard, Anna, Duarte Hernandez, Carlos Rene, Pihl, Anne Finne, Venkatesan, Nandini Prabhakar, Krarup, Henrik, Lin, Xiangliang, Reichl, Udo, Bukh, Jens, Genzel, Yvonne, Gottwein, Judith Margarete
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880717/
https://www.ncbi.nlm.nih.gov/pubmed/35214707
http://dx.doi.org/10.3390/vaccines10020249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880717/
https://www.ncbi.nlm.nih.gov/pubmed/35214707
http://dx.doi.org/10.3390/vaccines10020249

Ejemplares similares